ClinicalTrials.Veeva

Menu

Impact of Skeletal Muscle Quality and Loss on the Outcome of Liver Transplantation

Zhejiang University logo

Zhejiang University

Status

Not yet enrolling

Conditions

Liver Transplantation
Muscle Quality
Muscle Loss

Study type

Observational

Funder types

Other

Identifiers

NCT06188273
CT2023-ZJU-OBS3

Details and patient eligibility

About

CT imaging-based skeletal muscle assessment has been found to predict the outcomes of many diseases. Previous evidence revealed that pre-transplant muscle quality and post-transplant muscle loss were associated with transplant outcomes. However, there is no prospective study supporting the aforementioned conclusions. This study aims to prospectively include liver transplant patients from multiple transplant centers, collecting their pre-transplant CT images as well as post-transplant CT images at specific time points. The objective is to further explore and clarify the correlation between skeletal muscle assessment and the prognosis of liver transplant patients. The goal is to provide guidance for peri-transplant health monitoring and disease intervention for liver transplant patients.

Enrollment

800 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients undergoing deceased donor liver transplantation (DDLT) for the first time

Exclusion criteria

  • Pediatric transplants
  • Presence of portal vein tumor thrombus according to imageing before transplantation
  • Presence of macrovascular invasion according to imageing before transplantation
  • Re-transplants
  • Multi-organ transplants
  • Patients who died within 30 days after transplantation
  • Patients diagnosed with skeletal muscle diseases (e.g. muscle atrophy)
  • Patients with serious medical conditions such as heart failure, persistent infection, and renal insufficiency.

Trial design

800 participants in 4 patient groups

Myosteatotic Group
Description:
The group of patients was diagnosed with myosteatosis through CT imaging assessment before transplantation.
Non-myosteatotic Group
Description:
The group of patients was diagnosed without myosteatosis through CT imaging assessment before transplantation.
The Group with Severe Muscle Loss
Description:
The group of patients, through the comparison of CT images before and after transplantation, was diagnosed with significant muscle loss.
The Group without Severe Muscle Loss
Description:
The group of patients, through the comparison of CT images before and after transplantation, was diagnosed without significant muscle loss.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems